Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Pediatric Hepatology · Biliary Atresia

Life After Surgery: Recovery, Medications, and Long-Term Prognosis

At a Glance

After the Kasai procedure for biliary atresia, infants require specialized medications and vitamins to support liver function. A key success indicator is bilirubin dropping below 2.0 mg/dL, though 50-80% of children will still eventually need a liver transplant as a standard part of care.

The weeks and months following the Kasai portoenterostomy are a time of “watchful waiting.” Your medical team will monitor your baby closely to see if the surgery successfully restored bile flow, while also managing a complex regimen of medications and nutrition designed to support the liver’s recovery [1][2].

The Post-Operative Medication Regimen

To give the liver the best chance of success, most infants follow a multi-part medication and nutritional plan. Giving an infant 5 or more oral medications a day can be incredibly stressful; ask your pediatric pharmacist if a compounding pharmacy can flavor the medications to make them easier to administer.

  • Ursodeoxycholic Acid (Ursodiol): This is a naturally occurring bile acid that helps “thin” the bile, making it easier to flow through the new surgical connection [3].
  • Corticosteroids (Steroids): These are often used in the first weeks after surgery to reduce inflammation and swelling at the site where the intestine was attached to the liver, which may help clear jaundice more quickly [4][5]. Note: Because steroids suppress the immune system, you must ask your hepatology team about the proper timing for your baby’s live-virus vaccines.
  • Prophylactic Antibiotics: Because the new connection allows bacteria from the intestine to potentially travel “up” into the liver, babies are often kept on low-dose antibiotics for several months to prevent ascending cholangitis (a serious liver infection) [2][6].
  • Fat-Soluble Vitamins (ADEK): Because the liver may still struggle to process fats, babies often cannot absorb vitamins A, D, E, and K from food alone. These must be given in a specialized, highly absorbable form [2].
  • MCT Nutrition: Many babies are started on a specialized formula containing Medium-Chain Triglycerides (MCT oil), which the body can absorb even when bile flow is low [2].

Measuring Success: Jaundice Clearance

The most important sign that the Kasai procedure is working is jaundice clearance. Doctors typically define this as a total bilirubin level dropping below 2.0 mg/dL [7][8].

If your child reaches this milestone within 3 to 6 months after surgery, it is a strong predictor of Native Liver Survival (NLS)—meaning they have a much higher chance of living with their original liver for many years [9][10].

Long-Term Risks to Watch For

Even with a successful surgery, the liver requires lifelong monitoring for two main complications:

  1. Ascending Cholangitis: This is an infection of the bile ducts. Parents must watch for the “Triad of Signs”: fever, a sudden return of yellowing (jaundice), and pale stools [11][12]. Any fever in a child with biliary atresia is considered a medical emergency until proven otherwise.
  2. Portal Hypertension: Over time, scarring (fibrosis) in the liver can increase pressure in the veins leading to the liver. This can cause the spleen to enlarge (splenomegaly) or lead to fluid buildup in the abdomen (ascites) [13][14].
    • EMERGENCY WARNING: Portal hypertension can lead to enlarged, fragile veins in the stomach and esophagus called varices. If your child vomits blood or has black, tarry stools, this is a sign of variceal bleeding and is an extreme medical emergency. Call 911 or go to the nearest ER immediately.

The Long-Term Outlook

It is important to hold two facts at once: the Kasai procedure is a life-saving first step, and for many, it is also a “bridge” to a future treatment.

  • Native Liver Survival: Approximately 25% to 50% of children will still be living with their own liver 10 years after surgery [15][16].
  • Liver Transplantation: Between 50% and 80% of children with biliary atresia will eventually require a liver transplant, often by age 10 [17][18].

A transplant is not a failure of the Kasai surgery. Instead, think of it as the secondary standard of care that allows children with biliary atresia to grow into healthy adults. Modern transplant outcomes are excellent, with 10-year survival rates for children often exceeding 90% [19][20].

Common questions in this guide

What is a good bilirubin level after the Kasai procedure?
The primary goal after surgery is to achieve jaundice clearance. Doctors typically define this success as a total bilirubin level dropping below 2.0 mg/dL within three to six months after the procedure.
Why does my baby need antibiotics after biliary atresia surgery?
Following the surgery, bacteria from the intestine can travel up the new surgical connection into the liver. Low-dose prophylactic antibiotics are given to prevent a serious, potentially life-threatening liver infection called ascending cholangitis.
What are the signs of ascending cholangitis in infants?
Parents should closely monitor for the classic triad of symptoms: a fever, a sudden return of yellowing in the skin or eyes, and pale stools. Any fever in a child with biliary atresia is considered a medical emergency and requires immediate medical attention.
Will my child eventually need a liver transplant even if the Kasai surgery works?
Yes, between 50% and 80% of children with biliary atresia will eventually need a liver transplant, often around age 10. This is not considered a failure of the initial surgery, but rather a standard secondary treatment that allows children to grow into healthy adults.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What was the total bilirubin level at my child's 3-month follow-up, and is it below the 2.0 mg/dL target?
  2. 2.What is the exact dosage and schedule for my child's ADEK vitamin supplements and Ursodiol?
  3. 3.How long do you recommend my child stay on prophylactic antibiotics to prevent cholangitis?
  4. 4.At what temperature should I bring my child to the emergency room for a suspected infection?
  5. 5.What are the signs of portal hypertension I should be looking for at home, such as changes in the abdomen or spleen?
  6. 6.Can we work with a compounding pharmacy to make these oral medications easier for my infant to take?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (20)
  1. 1

    [Kasai-hepatoportoenterostomy for the treatment of biliary atresia - What is important?]

    Madadi-Sanjani O, Herden U, Uecker M

    Chirurgie (Heidelberg, Germany) 2025; (96(6)):474-481 doi:10.1007/s00104-025-02259-2.

    PMID: 40016476
  2. 2

    Effect of medium chain triglycerides enriched formula on growth of biliary atresia patients after Kasai portoenterostomy.

    El-Koofy N, Mahmoud E, El Mougy F, et al.

    Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology 2024; (25(2)):188-193 doi:10.1016/j.ajg.2024.01.015.

    PMID: 38378358
  3. 3

    Outcomes of late Kasai portoenterostomy in biliary atresia: a single-center experience.

    Khayat A, Alamri AM, Saadah OI

    The Journal of international medical research 2021; (49(5)):3000605211012596 doi:10.1177/03000605211012596.

    PMID: 33947263
  4. 4

    Steroids after the Kasai procedure for biliary atresia: the effect of age at Kasai portoenterostomy.

    Tyraskis A, Davenport M

    Pediatric surgery international 2016; (32(3)):193-200 doi:10.1007/s00383-015-3836-3.

    PMID: 26590818
  5. 5

    Effect of combined ursodeoxycholic acid and glucocorticoid on the outcome of Kasai procedure: A systematic review and meta-analysis.

    Qiu JL, Shao MY, Xie WF, et al.

    Medicine 2018; (97(35)):e12005 doi:10.1097/MD.0000000000012005.

    PMID: 30170405
  6. 6

    Prophylactic Antibiotics for Prevention of Cholangitis in Patients With Biliary Atresia Status Post-Kasai Portoenterostomy: A Systematic Review.

    Decharun K, Leys CM, West KW, Finnell SM

    Clinical pediatrics 2016; (55(1)):66-72 doi:10.1177/0009922815594760.

    PMID: 26183324
  7. 7

    Preoperative alkaline phosphatase is a potential predictor of short-term outcome of surgery in infants with biliary atresia.

    Abdel-Aziz SA, Sira MM, Gad EH, et al.

    Clinical and experimental hepatology 2019; (5(2)):155-160 doi:10.5114/ceh.2019.85072.

    PMID: 31501792
  8. 8

    A Comparison of Laparoscopic-Modified Kasai Versus Conventional Open Kasai for Biliary Atresia in Infants: A Single-Center Experience.

    Li B, Chen WB, Xia SL

    Journal of laparoendoscopic & advanced surgical techniques. Part A 2023; (33(2)):226-230 doi:10.1089/lap.2022.0339.

    PMID: 36270014
  9. 9

    Predictors of Need for Liver Transplantation in Children Undergoing Hepatoportoenterostomy for Biliary Atresia.

    Ramos-Gonzalez G, Elisofon S, Dee EC, et al.

    Journal of pediatric surgery 2019; (54(6)):1127-1131 doi:10.1016/j.jpedsurg.2019.02.051.

    PMID: 30879751
  10. 10

    Total Serum Bilirubin within 3 Months of Hepatoportoenterostomy Predicts Short-Term Outcomes in Biliary Atresia.

    Shneider BL, Magee JC, Karpen SJ, et al.

    The Journal of pediatrics 2016; (170()):211-7.e1-2.

    PMID: 26725209
  11. 11

    Laparoscopic Kasai portoenterostomy for biliary atresia: first experience from Central Asia.

    Semash K, Nasirov M, Dzhanbekov T, Khudaybergenova A

    Frontiers in pediatrics 2025; (13()):1666539 doi:10.3389/fped.2025.1666539.

    PMID: 41113567
  12. 12

    Microbiology and clinical characteristics of acute cholangitis with their impact on mortality; a retrospective cross sectional study.

    Akhtar F, Siddique MZ, Raza A, et al.

    JPMA. The Journal of the Pakistan Medical Association 2020; (70(4)):607-612 doi:10.5455/JPMA.29747.

    PMID: 32296203
  13. 13

    Does the identity of the bacteria matter in post-Kasai cholangitis? A comparison between simple and intractable cholangitis.

    Chung PHY, Tam PKH, Wong KKY

    Journal of pediatric surgery 2018; (53(12)):2409-2411 doi:10.1016/j.jpedsurg.2018.08.028.

    PMID: 30257813
  14. 14

    Biliary atresia: 20-40-year follow-up with native liver in an Italian centre.

    Parolini F, Boroni G, Milianti S, et al.

    Journal of pediatric surgery 2019; (54(7)):1440-1444 doi:10.1016/j.jpedsurg.2018.10.060.

    PMID: 30502004
  15. 15

    The Epidemiology and Outcome of Biliary Atresia: Saudi Arabian National Study (2000-2018).

    Al-Hussaini A, Abanemai M, Alhebbi H, et al.

    Frontiers in pediatrics 2022; (10()):921948 doi:10.3389/fped.2022.921948.

    PMID: 35923790
  16. 16

    Long-term Results and Quality of Life Assessment in Biliary Atresia Patients: A 35-Year Experience in a Tertiary Hospital.

    Wong CWY, Chung PHY, Tam PKH, Wong KKY

    Journal of pediatric gastroenterology and nutrition 2018; (66(4)):570-574 doi:10.1097/MPG.0000000000001854.

    PMID: 29216021
  17. 17

    Long-term outcome and necessity of liver transplantation in infants with biliary atresia are independent of cytokine milieu in native liver and serum.

    Madadi-Sanjani O, Kuebler JF, Dippel S, et al.

    Cytokine 2018; (111()):382-388 doi:10.1016/j.cyto.2018.09.010.

    PMID: 30300856
  18. 18

    Ki67 expression at Kasai portoenterostomy as a prognostic factor in patients with biliary atresia.

    Yoshii D, Inomata Y, Komohara Y, et al.

    BJS open 2020; (4(5)):873-883 doi:10.1002/bjs5.50308.

    PMID: 32543770
  19. 19

    Living donor liver transplantation for biliary atresia: An analysis of 2085 cases in the registry of the Japanese Liver Transplantation Society.

    Kasahara M, Umeshita K, Sakamoto S, et al.

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2018; (18(3)):659-668 doi:10.1111/ajt.14489.

    PMID: 28889651
  20. 20

    Long-term outcomes in pediatric patients who underwent living donor liver transplantation for biliary atresia.

    Sanada Y, Sakuma Y, Onishi Y, et al.

    Surgery 2022; (171(6)):1671-1676 doi:10.1016/j.surg.2021.11.027.

    PMID: 35027207

This page provides educational information about post-operative care for biliary atresia. It does not replace professional medical advice; always consult your pediatric hepatology team regarding your baby's specific medication regimen and emergency protocols.

Get notified when new evidence is published on Isolated biliary atresia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.